GlassScriptPhysician profile
Steven W Cimerberg
NPI 1760667968
$256.34
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $35.66 · 2023: $27.09 · 2024: $71.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $80.58 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $80.58 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $139.37 | 2019-2024 | Rybelsus, Ozempic |
| Genentech USA, INC. | $35.66 | 2020 | |
| Lilly USA, LLC | $22.86 | 2024 | Mounjaro |
| Medicure Pharma INC. | $17.70 | 2024 | Zypitamag |
| Abbvie INC. | $14.11 | 2023 | Qulipta, Ubrelvy |
| Janssen Pharmaceuticals, INC | $13.66 | 2024 | Xarelto |
| Boston Scientific Corporation | $12.98 | 2023 | Watchman Flx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Cimerberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.